Grants > Novel Gene-Therapy Approach for Glaucoma
Updated On: Ene. 23, 2025
National Glaucoma Research Grant
Novel Gene-Therapy Approach for Glaucoma
Controlling Eye Pressure in New Ways
About the Research Project
Program
National Glaucoma Research
Award Type
Bold Ideas initiatives
Award Amount
$1,000,000
Active Dates
March 31, 2021 - June 30, 2024
Grant ID
CG2020004
Acknowledgement
Part D of Joint Research Award for a Collaborative Interinstitutional Grant.
Co-Principal Investigator(s)
Goals
The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.
Grants
Related Grants
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
National Glaucoma Research
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Samuel Herberg, PhD
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Samuel Herberg, PhD
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD